The stock options are subject to the terms and conditions of Xilio Therapeutics' 2022 Inducement Stock Incentive Plan, as well as the terms and conditions of the stock option agreement covering the ...
Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.
Shares of biopharmaceutical company Praxis Precision Medicines Inc. soared Thursday, boosted by the successful trial of a new drug to treat movement disorders. The drug, ulixacaltamide, targets ...
The MarketWatch News Department was not involved in the creation of this content. GRAND JUNCTION, Colo., Oct. 6, 2025 /PRNewswire/ -- Pinpoint Search Group, a leading cybersecurity recruitment firm, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback